Search hospitals > Florida > Fort Lauderdale
UM Sylvester Comprehensive Cancer Center at Plantation
Claim this profileFort Lauderdale, Florida 33324
Global Leader in Cancer
Global Leader in Lung Cancer
Conducts research for Breast cancer
Conducts research for Breast Cancer
Conducts research for Pancreatic Cancer
93 reported clinical trials
42 medical researchers
Summary
UM Sylvester Comprehensive Cancer Center at Plantation is a medical facility located in Fort Lauderdale, Florida. This center is recognized for care of Cancer, Lung Cancer, Breast cancer, Breast Cancer, Pancreatic Cancer and other specialties. UM Sylvester Comprehensive Cancer Center at Plantation is involved with conducting 93 clinical trials across 191 conditions. There are 42 research doctors associated with this hospital, such as Jose Lutzky, MD, Chukwuemeka (Emeka) V. Ikpeazu, Aman Chauhan, MD, and Macarena I. De La Fuente.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
KRAS positive
2Lung Cancer
Global LeaderStage IV
Stage III
Stage II
Top PIs
Jose Lutzky, MDUniversity of Miami5 years of reported clinical research
Expert in Melanoma
Studies Skin Cancer
20 reported clinical trials
41 drugs studied
Chukwuemeka (Emeka) V. IkpeazuUniversity of Miami Miller School of Medicine-Sylvester Cancer Center2 years of reported clinical research
Studies Cancer
Studies Pancreatic Cancer
13 reported clinical trials
34 drugs studied
Aman Chauhan, MDUniversity of Kentucky/Markey Cancer Center3 years of reported clinical research
Studies Neuroendocrine Tumors
Studies Carcinoid Tumor
12 reported clinical trials
20 drugs studied
Macarena I. De La FuenteUniversity of Miami Miller School of Medicine-Sylvester Cancer Center6 years of reported clinical research
Studies Brain Tumor
Studies Glioblastoma
12 reported clinical trials
27 drugs studied
Clinical Trials running at UM Sylvester Comprehensive Cancer Center at Plantation
Lung Cancer
Skin Cancer
Cancer
Ovarian Cancer
Prostate Cancer
Melanoma
Cutaneous Melanoma
Breast Cancer
Pancreatic Cancer
Breast cancer
Proton Craniospinal Radiation
for Cancer in the Brain and Spinal Cord
This phase III trial compares proton craniospinal irradiation (pCSI) to involved-field radiation therapy (IFRT) for the treatment of breast or non-small cell lung cancer that has spread from where it first started to the cerebrospinal fluid filled space that surrounds the brain and spinal cord (leptomeningeal metastasis). Patients with leptomeningeal metastasis (LM) may develop multiple areas of nervous system (neurologic) impairment that can be life-threatening. Radiation therapy (RT) effectively relieves local symptoms due to LM. RT uses high energy radiography (x-rays), particles, or radioactive seeds to kill cancer cells and shrink tumors. IFRT is commonly used to treat symptoms of LM. IFRT is radiation treatment that uses x-rays to treat specific areas of LM and to relieve and/or prevent symptoms. pCSI uses protons that can be directed with more accuracy than x-rays which allows treatment of the entire central nervous system space containing the cerebrospinal fluid (CSF), brain, and spinal cord. The pCSI treatment could delay the worsening of LM. Giving pCSI may be better than IFRT in treating LM in patients with breast or non-small cell lung cancer.
Recruiting2 awards Phase 33 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Radiation Therapy
for Brain Metastasis
This phase III trial compares the effectiveness of fractionated stereotactic radiosurgery (FSRS) to usual care stereotactic radiosurgery (SRS) in treating patients with cancer that has spread from where it first started to the brain. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. FSRS delivers a high dose of radiation to the tumor over 3 treatments. SRS is a type of external radiation therapy that uses special equipment to position the patient and precisely give a single large dose of radiation to a tumor. FSRS may be more effective compared to SRS in treating patients with cancer that has spread to the brain.
Recruiting2 awards Phase 312 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at UM Sylvester Comprehensive Cancer Center at Plantation?
UM Sylvester Comprehensive Cancer Center at Plantation is a medical facility located in Fort Lauderdale, Florida. This center is recognized for care of Cancer, Lung Cancer, Breast cancer, Breast Cancer, Pancreatic Cancer and other specialties. UM Sylvester Comprehensive Cancer Center at Plantation is involved with conducting 93 clinical trials across 191 conditions. There are 42 research doctors associated with this hospital, such as Jose Lutzky, MD, Chukwuemeka (Emeka) V. Ikpeazu, Aman Chauhan, MD, and Macarena I. De La Fuente.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.